Clinical Trial Update: Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating risk-adapted focal proton beam radiation and/or surgery combined with standard or intensified chemotherapy for rhabdomyosarcom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Rhabdomyosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING